Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hello Alpha vs Spry

Hello Alpha
Graded #352

Higher grade

vs+2.1000000000000014
Spry
Graded #409

Lower grade

The verdict

Hello Alpha takes it — 58.9/100 to 56.8/100.

Hello Alpha grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Hello Alpha (formerly Alpha Medical) is a US telehealth platform offering a full weight-loss lineup: branded GLP-1s including Wegovy, Ozempic, Rybelsus, Zepbound and Mounjaro, plus the oral GLP-1 Foundayo…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSpry +9
45
54
Dose & formulationEven
64
64
Clinical oversightHello Alpha +22
77
55
Labs & monitoringHello Alpha +2
54
52
FulfillmentHello Alpha +6
67
61
Contract termsSpry +14
41
55
Hello Alpha · left barSpry · right bar

The numbers

MetricHello AlphaSpry
WeighScore58.9/10056.8/100
GradeCC
Scorecard rank#352#409
SemaglutideNot disclosed$199/mo (starting dose, compounded)
TirzepatideNot disclosed$299/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Hello Alpha

Graded #352 · C

Strengths

  • Full branded GLP-1 lineup: Wegovy, Ozempic, Rybelsus, Zepbound, Mounjaro
  • Offers the oral GLP-1 Foundayo plus oral weight-loss medications
  • Works with insurance
  • Ongoing clinician care via online membership

Where it loses points

  • Cash pricing is not published on the public site
  • Full state list is not enumerated
  • Insurance coverage of the medication still depends on your plan
Spry

Graded #409 · C

Strengths

  • Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
  • Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
  • Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
  • No contracts or commitment required
  • LegitScript Certified with a public verification link

Where it loses points

  • Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
  • Intake reviewed by a nurse practitioner, not an MD
  • States served not disclosed publicly
  • Pharmacy partner not named, and 503A vs 503B designation not specified
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard